Has John Schwappach, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,532,111 in general payments to John Schwappach, MD across 500 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Schwappach, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Schwappach, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Schwappach, MD

Orthopaedic Surgery · Englewood, CONPI 1902863343

Payments from drug & device makers

$1,532,111in general payments, 2019–2025

Across 500 payments — averaging $3064.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$719K
Takeda Pharmaceuticals U.S.A., Inc.$546K
Regeneron$192K
Davol Inc.$37K
AstraZeneca$13K
US Implant Solutions, LLC$9K
plus $17K from 22 others

$42,442in research payments, 2019–2025

Across 78 payments — averaging $544.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$21K
Takeda Pharmaceuticals U.S.A., Inc.$21K

What the payments were for

Consulting fees$4,16413%
Travel & lodging$9,90232%
Food & beverage$9,91832%
Entertainment$320%
Other$7,22823%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	29	$718,947
Takeda Pharmaceuticals U.S.A., Inc.	117	$545,847
Regeneron	205	$191,811
Davol Inc.	3	$37,092
AstraZeneca	1	$12,500
US Implant Solutions, LLC	8	$8,553
Stryker	90	$7,739
DJO, LLC	1	$7,228
Smith+Nephew	9	$466
Omnilife Science, Inc	3	$314
Johnson & Johnson(2 entities)	5	$297
Medtronic(2 entities)	4	$285
KCI USA, Inc.	2	$245
Acumed LLC	2	$133
Innovation Technologies Inc	1	$123
Trice Medical, Inc.	1	$107
Paragon 28, Inc.	2	$59
Vertex	3	$51
Acera Surgical, Inc.	2	$51
Aroa Biosurgery Incorporated	2	$48
Avanos Medical	2	$41
Orthalign Inc	1	$35
Argentum Medical	1	$32
Bioventus LLC	2	$31
Pacira Pharmaceuticals Incorporated	1	$30
Molnlycke Health Care US, LLC	1	$16
Zimmer Biomet	1	$16
Si-bone, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,532,111 in reported general payments places this provider in the 95th percentile of 383 orthopaedic surgery providers in Colorado.

See all orthopaedic surgery providers in Colorado →

Medicare billing

Part B allowed, 2024

$121,591

Medicare patients

187

Services billed

2,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Piroxicam	34	$545
Oxycodone Hcl	46	$240
Meloxicam	52	$123
Tramadol Hcl	36	$98

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Englewood

Joseph AssiniEnglewood$574K
Steven MorganEnglewood$200K
Ryan CarrEnglewood$52K
Joel MattaVail$21M
Douglas DennisDenver$17.5M
Brian HaasDenver$5.1M
Theodore SchlegelGreenwood Village$5M
Charlie YangDenver$3.7M
Robert BessGreenwood Village$3.2M
Robert GreenhowLone Tree$2.8M

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →